These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28730937)

  • 1. Clay-based drug-delivery systems: what does the future hold?
    Giuseppe ; Riela S; Fakhrullin RF
    Ther Deliv; 2017 Jul; 8(8):633-646. PubMed ID: 28730937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halloysite clay nanotubes for life sciences applications: From drug encapsulation to bioscaffold.
    Santos AC; Ferreira C; Veiga F; Ribeiro AJ; Panchal A; Lvov Y; Agarwal A
    Adv Colloid Interface Sci; 2018 Jul; 257():58-70. PubMed ID: 29887382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clay nanoparticles as pharmaceutical carriers in drug delivery systems.
    Dong J; Cheng Z; Tan S; Zhu Q
    Expert Opin Drug Deliv; 2021 Jun; 18(6):695-714. PubMed ID: 33301349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halloysite Nanotubes and Sepiolite for Health Applications.
    Biddeci G; Spinelli G; Colomba P; Di Blasi F
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halloysite nanotubes in analytical sciences and in drug delivery: A review.
    Fizir M; Dramou P; Dahiru NS; Ruya W; Huang T; He H
    Mikrochim Acta; 2018 Jul; 185(8):389. PubMed ID: 30046919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoclay-based drug delivery systems and their therapeutic potentials.
    Khatoon N; Chu MQ; Zhou CH
    J Mater Chem B; 2020 Aug; 8(33):7335-7351. PubMed ID: 32687134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of halloysite tubule nanoclay in drug delivery.
    Lvov YM; DeVilliers MM; Fakhrullin RF
    Expert Opin Drug Deliv; 2016 Jul; 13(7):977-86. PubMed ID: 27027933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The systems containing clays and clay minerals from modified drug release: a review.
    Rodrigues LA; Figueiras A; Veiga F; de Freitas RM; Nunes LC; da Silva Filho EC; da Silva Leite CM
    Colloids Surf B Biointerfaces; 2013 Mar; 103():642-51. PubMed ID: 23253474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clay minerals: Properties and applications to dermocosmetic products and perspectives of natural raw materials for therapeutic purposes-A review.
    Moraes JDD; Bertolino SRA; Cuffini SL; Ducart DF; Bretzke PE; Leonardi GR
    Int J Pharm; 2017 Dec; 534(1-2):213-219. PubMed ID: 29038067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Past, Present and Future Perspectives on Halloysite Clay Minerals.
    Massaro M; Noto R; Riela S
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33096852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halloysite nanotubes - the nano-bio interface.
    Prinz Setter O; Segal E
    Nanoscale; 2020 Dec; 12(46):23444-23460. PubMed ID: 33237090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halloysite clay nanotubes for tissue engineering.
    Fakhrullin RF; Lvov YM
    Nanomedicine (Lond); 2016 Sep; 11(17):2243-6. PubMed ID: 27527682
    [No Abstract]   [Full Text] [Related]  

  • 13. Clay nanotube encapsulation for functional biocomposites.
    Lvov Y; Aerov A; Fakhrullin R
    Adv Colloid Interface Sci; 2014 May; 207():189-98. PubMed ID: 24268974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysaccharides/Halloysite nanotubes for smart bionanocomposite materials.
    Bertolino V; Cavallaro G; Milioto S; Lazzara G
    Carbohydr Polym; 2020 Oct; 245():116502. PubMed ID: 32718613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart H
    Liu F; Bai L; Zhang H; Song H; Hu L; Wu Y; Ba X
    ACS Appl Mater Interfaces; 2017 Sep; 9(37):31626-31633. PubMed ID: 28862828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytocompatibility and uptake of halloysite clay nanotubes.
    Vergaro V; Abdullayev E; Lvov YM; Zeitoun A; Cingolani R; Rinaldi R; Leporatti S
    Biomacromolecules; 2010 Mar; 11(3):820-6. PubMed ID: 20170093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrous Clays in Dermopharmaceutical and Cosmetic Applications: Traditional and Emerging Perspectives.
    Cao L; Xie W; Cui H; Xiong Z; Tang Y; Zhang X; Feng Y
    Int J Pharm; 2022 Sep; 625():122097. PubMed ID: 35952800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubule Nanoclay-Organic Heterostructures for Biomedical Applications.
    Liu M; Fakhrullin R; Novikov A; Panchal A; Lvov Y
    Macromol Biosci; 2019 Apr; 19(4):e1800419. PubMed ID: 30565394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of halloysite clay nanotubes as a pharmaceutical excipient.
    Yendluri R; Otto DP; De Villiers MM; Vinokurov V; Lvov YM
    Int J Pharm; 2017 Apr; 521(1-2):267-273. PubMed ID: 28235623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of halloysite nanotubes for controlled loading and release.
    Massaro M; Cavallaro G; Colletti CG; Lazzara G; Milioto S; Noto R; Riela S
    J Mater Chem B; 2018 Jun; 6(21):3415-3433. PubMed ID: 32254440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.